Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
IRWD Revenue Growth (YoY Quarterly)•-47.31%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-47.31%
-80.6pp
-47.82%
-145.4pp
-73.64%
-255.5pp
-79.19%
-273.6pp
-200.89%
-1200.2pp
-199.29%
-1195.8pp
-190.78%
-1099.6pp
+1.45%
-0.1pp
+10.81%
-0.1pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -22.98% | -45.05% | -9.70% | +33.26% | -47.31% |
| Gross Profit Growth | -22.98% | -72.05% | -9.70% | +97.62% | -47.82% |
| EBITDA Growth | -17.61% | -184.13% | +73.71% | +181.84% | -73.64% |
| Operating Income Growth | -16.22% | -364.14% | +81.45% | +194.45% | -79.19% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +999.29% | -200.89% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +996.49% | -199.29% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +908.77% | -190.78% |
| Weighted Average Shares Growth | +2.49% | +2.08% | +1.70% | +1.57% | +1.45% |
| Weighted Average Shares Diluted Growth | +2.82% | +2.08% | +1.70% | +10.94% | +10.81% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -57.54% | -55.64% | -145.03% | +381.37% | +390.17% |
| Free Cash Flow Growth | -57.29% | -55.64% | -145.11% | +382.13% | +390.18% |
| Receivables Growth | -36.58% | -44.78% | +48.30% | +57.96% | -42.91% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -25.51% | -25.43% | -13.31% | +1.68% | +13.11% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -16.22% | -13.23% | -6.50% | -2.70% | -0.28% |
| R&D Expense Growth | -28.83% | +6.26% | -23.08% | -24.67% | -13.89% |
| SG&A Expenses Growth | -13.13% | +0.00% | -54.56% | -39.33% | -42.56% |
1 / 4